Outcomes of drug-induced acute pancreatitis: a ten-year experience of an academic center

Rev Esp Enferm Dig. 2021 Apr;113(4):276-279. doi: 10.17235/reed.2020.7443/2020.

Abstract

Background: drug-induced pancreatitis is an unexplored entity.

Methods: a retrospective cohort study was performed at a referral center. Patients with drug-induced acute pancreatitis between 2008 and 2018 were included. Baseline patient characteristics, involved drugs, clinical course and recurrence were analyzed.

Results: drug-induced pancreatitis represented 2.8 % of acute pancreatitis (47/1,665) and 18 different drugs were involved (thiopurines 61.8 %). The latency period was less than one month in 87.2 % of cases. Pancreatitis was mild in 89.3 % and recurrence risk was 2.3 %.

Conclusion: drugs are a rare cause of pancreatitis, which mostly occurs within the first month of treatment, is usually mild and is associated with a low risk of recurrence.

MeSH terms

  • Acute Disease
  • Humans
  • Pancreatitis* / chemically induced
  • Pancreatitis* / epidemiology
  • Pharmaceutical Preparations*
  • Recurrence
  • Retrospective Studies

Substances

  • Pharmaceutical Preparations